John Hovanesian, Hawaiian Eye and Retina 2023: Insights from 20 years of premium intraocular lens implants
A premium intraocular lens (IOL) is a type of IOL used in cataract patients that are designed to provide near, intermediate, and distance vision without glasses or contacts. In this touchOPHTHALMOLOGY interview, Dr John Hovanesian (Harvard Eye Associates CA, USA) discusses presents his Hawaiian Eye presentation on premium lens implants and the lessons on how to to best use them in practice.
The abstract entitled ‘“What Have You Learned, Dorothy?” Insights from 20+ Years of Premium Implants’ was presented at Hawaiian Eye and Retina meeting, 14-20 January 2023.
Questions:
- Can you summarise your Hawaiian Eye 2023 presentation? (0:08)
Disclosures: John Hovanesian is a consultant for Acufocus, Aerie, Alcon, Allergan, Apellis, Avellino Labs USA, Azura Ophthalmics, BlephEx, Cloudbreak Therapeutix, Cord, LLC, ECRI, Eyedetec, EyePoint, Glaukos, Glaxo Smithcline, Glint Pharma, Gobiquity, Guardion Health Sciences, Imprimis, Ingenoeye LLC, Johnson & Johnson Vision, Kala, Novartis, Ocular Therapeutix, Oculis, Omeros, On Point Vision, Orasis, Oyster Point Pharma, Research InSight LLC, Sensimed, SightLife, Sun Pharma, Tarsus, Tearlab, Touch Ophthalmology, Vindico Medical Education, Visus and Zeiss and discloses grant/research support from Acufocus, Aerie, Alcon, Allergan, Bausch & Lomb, Cord, LLC, EyePoint, Glaukos, Imprimis, Ingenoeye LLC, Johnson & Johnson Vision, Novartis, Ocular Therapeutix, Omeros, On Point Vision, Research InSight LLC, Sight Sciences, Sun Pharma and Zeiss.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Shanice Allen.
Filmed as a highlight of Hawaiian Eye
Access more content on Cataract Surgery here
